• Concanavalin A Targets Conserved N-Glycans in Coronavirus Sp

  2026-05-29

  This study uncovers how the plant lectin concanavalin A (ConA) inhibits a broad range of coronaviruses by binding to conserved N-linked glycans on the spike protein, thereby blocking membrane fusion and viral entry. The findings suggest that targeting these stable glycosylation sites offers a promising new strategy for developing broad-spectrum antiviral agents.

• Angiotensin II-HIF-1α Axis Suppresses Ferroptosis in NPC Rad

  2026-05-29

  This study elucidates how local angiotensin II (Ang II) fosters radioresistance in nasopharyngeal carcinoma (NPC) by suppressing ferroptosis through the HIF-1α-HILPDA axis. The findings reveal actionable molecular targets for enhancing NPC radiosensitivity, suggesting that combined inhibition of Ang II signaling and induction of ferroptosis may improve radiotherapy outcomes.

• RG108: Precision DNA Methyltransferase Inhibition for Advanc

  2026-05-28

  Explore how RG108, a potent DNA methyltransferase inhibitor, enables precise epigenetic gene regulation and tumor suppressor gene reactivation. This article provides a unique, in-depth analysis of RG108’s in vivo kinetics and practical assay optimization for advanced cancer research.

• Quercetin as a PI3K Inhibitor: Applied Workflows in Cancer &

  2026-05-28

  Quercetin enables precise modulation of PI3K and neuroinflammatory pathways, making it a versatile tool for both cancer and depression research. This guide details experimental workflows, troubleshooting strategies, and key protocol factors to maximize reproducibility and interpretability in cell-based and in vivo assays.

• Recombinant Human Oncostatin M: Applied Workflows & Assay Po

  2026-05-27

  Recombinant Human Oncostatin M (rh-Oncostatin M) from APExBIO empowers robust, reproducible cytokine-driven assays—enabling advanced cell proliferation, cytokine release, and disease modeling. Discover protocol refinements, troubleshooting insights, and translational applications that set this high-purity, tag-free cytokine apart.

• Methylprednisolone Sodium Succinate: Workflows for Inflammat

  2026-05-27

  Methylprednisolone Sodium Succinate stands out for its precision and reproducibility in inflammation and immunology research, enabling nuanced cytokine suppression and apoptosis assays. This guide details experimental workflows, troubleshooting strategies, and advanced applications, helping scientists accelerate translational insight and assay reliability.

• Septin4 Drives Cardiomyocyte Injury via VHL-Dependent HIF-1α

  2026-05-26

  This study reveals that Septin4 exacerbates hypoxia-induced cardiomyocyte apoptosis by enhancing HIF-1α ubiquitination and degradation through the VHL pathway. The findings highlight a novel regulatory axis in myocardial ischemia, offering mechanistic insights for therapeutic targeting of HIF stabilization in cardiovascular injury.

• GI 254023X: Applied Workflows with a Selective ADAM10 Inhibi

  2026-05-26

  GI 254023X empowers high-precision studies of ADAM10-mediated signaling, offering robust selectivity and actionable advantages in models of apoptosis, vascular integrity, and infection-induced injury. This guide translates recent reference findings and best practices into reliable, reproducible protocols for advanced cell biology and translational research.

• GI 254023X: Precision ADAM10 Inhibitor for Advanced Cell Mod

  2026-05-25

  GI 254023X empowers researchers to dissect ADAM10-dependent signaling, apoptosis, and vascular integrity with nanomolar selectivity and robust experimental flexibility. Its validated protocols accelerate translational modeling—especially where off-target effects of broader metalloprotease inhibitors have limited data reliability.

• Aprotinin in Translational Research: Membrane Rigidity to Bl

  2026-05-25

  This thought-leadership article illuminates how aprotinin (bovine pancreatic trypsin inhibitor) intersects mechanistic membrane biophysics with advanced cardiovascular blood management, equipping translational researchers with actionable insights and protocol guidance. Integrating recent findings on red blood cell membrane bending rigidity with the evolving landscape of serine protease signaling, we contextualize APExBIO's aprotinin as a versatile tool for both mechanistic discovery and blood conservation strategies.

• Bafilomycin C1: Advanced Workflows for V-ATPase Inhibition

  2026-05-24

  Bafilomycin C1 empowers high-content phenotypic assays by reliably inhibiting vacuolar H+-ATPases, enabling precise dissection of autophagy and lysosomal pathways. Its high purity and robust performance make it indispensable for scalable drug toxicity screening and advanced disease modeling.

• Optimizing Immunoassays with the c-Myc tag Peptide: Protocol

  2026-05-23

  The c-Myc tag Peptide from APExBIO delivers robust displacement of c-Myc-tagged fusion proteins in immunoassays, driving precision in transcription factor and cancer biology studies. Explore protocol enhancements, advanced applications, and troubleshooting strategies to maximize assay reliability and scientific reproducibility.

• PPM-18 for iNOS Inhibition: Protocols and Sepsis Research In

  2026-05-22

  PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) delivers robust, reproducible inhibition of iNOS via NF-κB pathway targeting, making it a standout tool for inflammation and sepsis research. This guide distills advanced workflows, troubleshooting strategies, and actionable insights to help researchers maximize experimental reliability and data quality.

• JSH-23: Precision NF-κB Inhibitor Workflows for Inflammation

  2026-05-22

  JSH-23 stands out as a selective small-molecule NF-κB inhibitor, enabling targeted dissection of inflammation pathways in both cell culture and animal models. This guide delivers actionable protocols, troubleshooting strategies, and experimental context to maximize reproducibility and insight using JSH-23 from APExBIO.

• SAR131675: Precision VEGFR-3 Inhibitor Workflows & Optimizat

  2026-05-21

  SAR131675 is redefining anti-lymphangiogenic and anti-angiogenic research by offering unparalleled selectivity for VEGFR-3, enabling rigorous pathway dissection in oncology and fibrosis models. This guide translates bench findings and recent reference insights into actionable protocols, troubleshooting tactics, and strategic perspectives for advanced experimental design.

15961 records 1/1065 page Next 12345 下5页 Last page